间歇性跛行患者下肢旁路术后并发症的风险调整住院费用量化
基于2009-2015年医疗数据库,纳入7154例首次因间歇性跛行行择期下肢旁路术的患者,分析术后并发症与住院费用的关系。术后并发症发生率为8.5%,风险调整后并发症使住院费用增加6183至10485美元(增幅46%-78%)。作者认为对跛行患者应审慎选择血运重建。
要点
- 择期下肢旁路术后院内并发症发生率为8.5%,以急性肾损伤(3.0%)和主要不良肢体事件(2.8%)为主。
- 风险调整后,主要不良肢体事件增加费用6183美元,主要不良心脏事件增加10485美元。
- 并发症使住院费用增加46%-78%,提示对跛行患者应严格筛选血运重建指征。
核心结论
- 择期下肢旁路术后并发症并非少见,风险调整后使住院费用增加46%-78%。
- 对间歇性跛行患者行外科血运重建应谨慎选择合适人群。
研究设计与样本
- 基于2009-2015年医疗数据库的回顾性队列研究,纳入7154例首次因间歇性跛行行择期下肢旁路术的患者。
- 采用广义线性模型(对数链接、逆高斯分布)计算特定并发症的预测住院费用。
主要发现
- 患者中位年龄66岁(四分位距59-73岁),男性占67.5%,白人占75.3%。
- 院内并发症发生率为8.5%,其中急性肾损伤3.0%、主要不良肢体事件2.8%、伤口并发症2.3%、主要不良心脏事件1.0%。
- 总体中位粗住院费用为11783美元(四分位距8911-15767美元)。
- 风险调整后,主要不良肢体事件增加费用6183美元(95%CI 4604-7762),主要不良心脏事件增加10485美元(95%CI 6529-14441)。
临床怎么用
- 在与跛行患者共同决策时,应将术后并发症带来的额外住院费用(约6183-10485美元)纳入考量。
- 对合并症较多、并发症风险高的跛行患者,应优先考虑非手术治疗或更谨慎地选择血运重建方式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Increasing evidence has shown that the risks associated with surgical revascularization for intermittent claudication outweigh the benefits. The aim of our study was to quantify the cost of care associated with perioperative complications after elective lower extremity bypass (LEB) in patients presenting with intermittent claudication. METHODS: All patients undergoing first-time LEB for claudication in the Healthcare Database (2009-2015) were included. The primary outcome was in-hospital postoperative complications, including major adverse limb events (MALE), major adverse cardiac events (MACE), acute kidney injury, and wound complications. The overall crude hospital costs are reported, and a generalized linear model with log link and inverse Gaussian distribution was used to calculate the predicted hospital costs for specific complications. RESULTS: Overall, 7154 patients had undergone elective LEB for claudication during the study period. The median age was 66 years (interquartile range, 59-73 years), 67.5% were male, and 75.3% were white. Two thirds of patients (61.2%) had Medicare insurance, followed by private insurance (26.9%), Medicaid (7.7%), and other insurance (4.2%). In-hospital complications occurred in 8.5% of patients, including acute kidney injury in 3.0%, MALE in 2.8%, wound complications in 2.3%, and MACE in 1.0%. The overall median crude hospital cost was $11,783 (interquartile range, $8911-$15,767) per patient. The incremental increase in cost associated with a postoperative complication was significant, ranging from $6183 (95% confidence interval, $4604-$7762) for MALE to $10,485 (95% confidence interval, $6529-$14,441) for MACE after risk adjustment. CONCLUSIONS: Postoperative complications after elective LEB for claudication are not uncommon and increase the in-hospital costs by 46% to 78% depending on the complication. Surgical revascularization for claudication should be used sparingly in carefully selected patients.
引用
- Sorber R, Alshaikh HN, Nejim B, et al. Quantifying the risk-adjusted hospital costs of postoperative complications after lower extremity bypass in patients with claudication. J Vasc Surg. 2020. PMID: 32931872. doi:10.1016/j.jvs.2020.08.130
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。